Description

This curriculum spans the full lifecycle of a gene knockout study, equivalent in scope to a multi-phase research program integrating experimental design, multi-omics data generation, bioinformatics analysis, and rigorous validation, as conducted in academic-industry collaborative projects or institutional core facility workflows.

Module 1: Defining Gene Knockout Objectives and Experimental Scope

Select appropriate model organisms based on genetic tractability, homology to human genes, and availability of validated knockout strains.
Determine whether to pursue full-body or conditional (tissue-specific, inducible) knockout based on gene essentiality and phenotypic lethality risks.
Justify use of CRISPR-Cas9 over alternative methods (e.g., TALENs, homologous recombination) based on throughput, cost, and off-target risk tolerance.
Define primary phenotypic endpoints (e.g., viability, metabolic function, behavioral assays) to align sequencing with functional validation.
Establish power requirements and sample size for downstream RNA-seq or proteomics to detect meaningful expression changes post-knockout.
Document exclusion criteria for genes with paralogs or compensatory pathways that may mask knockout effects.
Negotiate access to institutional animal facilities or cell line repositories early in planning to avoid timeline delays.
Integrate ethical review board (IACUC or equivalent) requirements into experimental design documentation.

Module 2: Reference Genome Selection and Annotation Curation

Choose between reference genome versions (e.g., GRCh38 vs. GRCh39) based on annotation completeness and tool compatibility.
Validate gene boundaries using multiple databases (Ensembl, RefSeq, GENCODE) to resolve discrepancies in exon-intron structure.
Identify pseudogenes and repetitive regions near the target locus to avoid guide RNA misalignment.
Map known SNPs and structural variants in the strain or population background to prevent interference with gRNA binding.
Curate splice isoforms to determine which transcript variant(s) the knockout should disrupt.
Integrate tissue-specific expression data (e.g., GTEx) to assess functional relevance in relevant biological contexts.
Flag overlapping genes or bidirectional promoters that could result in unintended regulatory effects.
Version-control all annotation files and document sources to ensure reproducibility across analysis pipelines.

Module 3: gRNA Design and Off-Target Risk Assessment

Apply multiple gRNA scoring algorithms (e.g., Doench 2016, CFD score) and reconcile conflicting predictions.
Exclude gRNAs with seed regions matching more than two locations in the genome using BLAST or Bowtie2.
Use chromatin accessibility data (e.g., ATAC-seq) to prioritize gRNAs in open chromatin regions for higher editing efficiency.
Design paired gRNAs for complete exon excision when frameshifts alone are insufficient to ensure functional knockout.
Include mismatch tolerance analysis to evaluate potential off-target sites with up to three base mismatches.
Validate gRNA specificity across related cell types or developmental stages if working with dynamic systems.
Depositor gRNA sequences in public repositories (e.g., Addgene) with detailed experimental context for traceability.
Balance efficiency and specificity by selecting gRNAs with high on-target scores and minimal predicted off-target sites.

Module 4: Wet-Lab Execution and Quality Control

Optimize delivery method (electroporation, viral transduction, microinjection) based on cell type and editing efficiency benchmarks.

Include appropriate controls: non-targeting gRNA, untreated cells, and wild-type isogenic lines.

Perform Sanger sequencing or NGS of targeted loci to confirm indel patterns and biallelic disruption.

Quantify editing efficiency using T7E1 assays or digital droplet PCR in early pilot experiments.

Establish cell line stability by passaging edited clones and retesting genotype over multiple generations.

Freeze down multiple clonal isolates to preserve genetic heterogeneity and avoid monoclonal artifacts.

Monitor cell viability and proliferation rates post-editing to detect unintended fitness costs.

Document all reagent lots, buffer compositions, and instrument settings for protocol replication.

Module 5: Multi-Omics Data Acquisition and Integration

Coordinate RNA-seq library preparation with matched genomic DNA extraction for joint variant and expression analysis.
Normalize sequencing depth across knockout and control samples to avoid batch-driven expression artifacts.
Include ribosomal RNA depletion or poly-A selection based on expected transcript types and degradation state.
Integrate proteomics (e.g., LC-MS/MS) only when post-translational regulation is suspected to affect phenotype.
Apply spike-in controls (e.g., ERCC) to assess technical variability in low-expression genes.
Time metabolomics sampling post-knockout to capture acute versus chronic metabolic shifts.
Use single-cell RNA-seq when tissue heterogeneity may obscure cell-type-specific knockout effects.
Ensure raw data is stored in FAIR-compliant formats with metadata describing experimental conditions.

Module 6: Bioinformatics Analysis of Knockout Effects

Align RNA-seq reads using splice-aware aligners (e.g., STAR) with genome indexes built from updated annotations.
Apply differential expression tools (e.g., DESeq2, edgeR) with proper design matrices to account for batch and clone effects.
Filter out genes with low counts across all samples to reduce false positives in downstream pathway analysis.
Validate absence of target gene expression using read coverage plots across exons and splice junctions.
Perform isoform-level analysis (e.g., with Salmon or kallisto) if alternative splicing is a potential compensation mechanism.
Correlate expression changes with chromatin interaction data (e.g., Hi-C) to identify distal regulatory impacts.
Compare knockout-induced signatures against public databases (e.g., LINCS, GEO) to identify similar perturbations.
Integrate CNV and SNP data from WGS to rule out confounding genomic alterations in clonal lines.

Module 7: Pathway and Network Interpretation

Select pathway databases (e.g., KEGG, Reactome, MSigDB) based on curation depth and tissue relevance.
Apply over-representation analysis cautiously, adjusting for gene length and GC content biases.
Use gene set variation analysis (GSVA) to assess pathway activity changes without arbitrary expression thresholds.
Infer upstream regulators using tools like IPA or SCENIC when transcription factors show indirect regulation.
Construct protein-protein interaction networks (e.g., via STRING) to identify functional modules disrupted by knockout.
Distinguish direct from indirect effects by overlaying ChIP-seq or TF binding motif data.
Validate network predictions with orthogonal data, such as phosphoproteomics for signaling pathways.
Document all software parameters and database versions to support auditability of enrichment results.

Module 8: Validation and Functional Rescue Experiments

Design rescue constructs with silent mutations in the gRNA target site to prevent re-cleavage.
Choose between transient transfection and stable integration for rescue expression based on protein half-life.
Validate rescue at both molecular (protein expression) and phenotypic (functional assay) levels.
Use inducible systems to control timing of rescue expression and assess reversibility of phenotypes.
Compare rescue outcomes across multiple clonal lines to rule out site-of-integration artifacts.
Include dose-response testing when expressing the gene under different promoters to assess expression-phenotype relationships.
Employ complementary techniques (e.g., siRNA, small molecule inhibitors) to confirm phenotype specificity.
Archive all validation data with raw images, quantification scripts, and blinding procedures documented.

Module 9: Data Governance, Reproducibility, and Knowledge Transfer

Implement version-controlled analysis pipelines using Snakemake or Nextflow to ensure computational reproducibility.
Register experiments in public repositories (e.g., protocols.io) with detailed step-by-step documentation.
Deposit raw sequencing data in INSDC databases (e.g., SRA) with compliant metadata and controlled vocabularies.
Apply persistent identifiers (DOIs) to datasets and code repositories for citation and tracking.
Define data retention policies aligned with institutional and funder requirements (e.g., NIH, Horizon Europe).
Conduct internal code reviews for all analysis scripts to reduce logic errors and improve maintainability.
Standardize reporting of editing efficiency, sample n, and statistical thresholds across publications.
Establish data use agreements when sharing cell lines or datasets with external collaborators.